Raras
Buscar doenças, sintomas, genes...
Síndrome adrenogenital
ORPHA:181412CID-10 · E25CID-11 · 5A71DOENÇA RARA

Diferenciação sexual anormal ou distúrbios congênitos do desenvolvimento sexual causados ​​por níveis anormais de hormônios esteróides expressos pelas gônadas ou pelas glândulas supra-renais, como na hiperplasia adrenal congênita e nas neoplasias do córtex adrenal. Devido à biossíntese anormal de esteróides, as características clínicas incluem virilismo em mulheres; feminização em homens; ou desenvolvimento sexual precoce em crianças.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Diferenciação sexual anormal ou distúrbios congênitos do desenvolvimento sexual causados ​​por níveis anormais de hormônios esteróides expressos pelas gônadas ou pelas glândulas supra-renais, como na hiperplasia adrenal congênita e nas neoplasias do córtex adrenal. Devido à biossíntese anormal de esteróides, as características clínicas incluem virilismo em mulheres; feminização em homens; ou desenvolvimento sexual precoce em crianças.

Publicações científicas
1.178 artigos
Último publicado: 2025 Jun 30
Medicamentos
10 registrados
PREDNISOLONE, CORTISONE ACETATE, DEXAMETHASONE SODIUM PHOSPHATE

Tem tratamento?

10 medicamentos registrados
Ver detalhes, fases e interações →
PREDNISOLONECORTISONE ACETATEDEXAMETHASONE SODIUM PHOSPHATEDEXAMETHASONEHYDROCORTISONEPREDNISONEFLUDROCORTISONE ACETATECRINECERFONTNEVANIMIBEABIRATERONE ACETATE
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: E25
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🦴
Ossos e articulações
26 sintomas
📏
Crescimento
21 sintomas
🫘
Rins
14 sintomas
😀
Face
8 sintomas
🫃
Digestivo
6 sintomas
🧠
Neurológico
5 sintomas

+ 139 sintomas em outras categorias

Características mais comuns

Hipertrofia clitoriana
Pseudo-hermafroditismo feminino
Nível anormal de testosterona
Aumento do nível urinário de cortisol
Acidente vascular cerebral
Anormalidade da anti-hélice
235sintomas
Sem dados (235)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 235 características clínicas mais associadas, ordenadas por frequência.

Hipertrofia clitorianaClitoral hypertrophy
Pseudo-hermafroditismo femininoFemale pseudohermaphroditism
Nível anormal de testosteronaAbnormal testosterone level
Aumento do nível urinário de cortisolIncreased urinary cortisol level
Acidente vascular cerebralStroke

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2025
Total histórico1.178PubMed
Últimos 10 anos30publicações
Pico20164 papers
Linha do tempo
2025Hoje · 2026🧪 1993Primeiro ensaio clínico📈 2016Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

9 genes identificados com associação a esta condição.

CYP21A2Steroid 21-hydroxylaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

A cytochrome P450 monooxygenase that plays a major role in adrenal steroidogenesis. Catalyzes the hydroxylation at C-21 of progesterone and 17alpha-hydroxyprogesterone to respectively form 11-deoxycorticosterone and 11-deoxycortisol, intermediate metabolites in the biosynthetic pathway of mineralocorticoids and glucocorticoids (PubMed:10602386, PubMed:16984992, PubMed:22014889, PubMed:25855791, PubMed:27721825). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, a

LOCALIZAÇÃO

Endoplasmic reticulum membraneMicrosome membrane

VIAS BIOLÓGICAS (3)
Glucocorticoid biosynthesisEndogenous sterolsMineralocorticoid biosynthesis
MECANISMO DE DOENÇA

Adrenal hyperplasia 3

A form of congenital adrenal hyperplasia, a common recessive disease due to defective synthesis of cortisol. Congenital adrenal hyperplasia is characterized by androgen excess leading to ambiguous genitalia in affected females, rapid somatic growth during childhood in both sexes with premature closure of the epiphyses and short adult stature. Four clinical types: 'salt wasting' (SW, the most severe type), 'simple virilizing' (SV, less severely affected patients), with normal aldosterone biosynthesis, 'non-classic form' or late-onset (NC or LOAH) and 'cryptic' (asymptomatic).

EXPRESSÃO TECIDUAL(Tecido-específico)
Glândula adrenal
1673.2 TPM
Fígado
17.5 TPM
Ovário
4.6 TPM
Baço
3.3 TPM
Fallopian Tube
3.2 TPM
OUTRAS DOENÇAS (3)
classic congenital adrenal hyperplasia due to 21-hydroxylase deficiencyclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing formclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form
HGNC:2600UniProt:P08686
STARGuanylyl cyclase CDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Guanylyl cyclase that catalyzes synthesis of cyclic GMP (cGMP) from GTP (PubMed:11950846, PubMed:1718270, PubMed:22436048, PubMed:22521417, PubMed:23269669). Receptor for the E.coli heat-stable enterotoxin; E.coli enterotoxin markedly stimulates the accumulation of cGMP in mammalian cells expressing GUCY2C (PubMed:1680854, PubMed:1718270). Also activated by the endogenous peptides guanylin and uroguanylin (PubMed:8381596)

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Pregnenolone biosynthesis
MECANISMO DE DOENÇA

Diarrhea 6

A relatively mild, early-onset chronic diarrhea that may be associated with increased susceptibility to inflammatory bowel disease, small bowel obstruction, and esophagitis.

EXPRESSÃO TECIDUAL(Tecido-específico)
Glândula adrenal
4912.2 TPM
Ovário
925.7 TPM
Testículo
73.5 TPM
Brain Frontal Cortex BA9
6.5 TPM
Hipotálamo
5.9 TPM
OUTRAS DOENÇAS (4)
congenital lipoid adrenal hyperplasia due to STAR deficencyfamilial glucocorticoid deficiencynon-classic congenital lipoid adrenal hyperplasia due to STAR deficencyclassic congenital lipoid adrenal hyperplasia due to STAR deficency
HGNC:11359UniProt:P25092
CYP11B1Cytochrome P450 11B1, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

A cytochrome P450 monooxygenase involved in the biosynthesis of adrenal corticoids (PubMed:12530636, PubMed:1518866, PubMed:1775135, PubMed:18215163, PubMed:23322723). Catalyzes a variety of reactions that are essential for many species, including detoxification, defense, and the formation of endogenous chemicals like steroid hormones. Steroid 11beta, 18- and 19-hydroxylase with preferred regioselectivity at 11beta, then 18, and lastly 19 (By similarity). Catalyzes the hydroxylation of 11-deoxyc

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Endogenous sterolsGlucocorticoid biosynthesis
MECANISMO DE DOENÇA

Adrenal hyperplasia 4

A form of congenital adrenal hyperplasia, a common recessive disease due to defective synthesis of cortisol. Congenital adrenal hyperplasia is characterized by androgen excess leading to ambiguous genitalia in affected females, rapid somatic growth during childhood in both sexes with premature closure of the epiphyses and short adult stature. Four clinical types: 'salt wasting' (SW, the most severe type), 'simple virilizing' (SV, less severely affected patients), with normal aldosterone biosynthesis, 'non-classic form' or late-onset (NC or LOAH) and 'cryptic' (asymptomatic).

EXPRESSÃO TECIDUAL(Tecido-específico)
Glândula adrenal
4787.3 TPM
Testículo
6.4 TPM
Cervix Ectocervix
0.9 TPM
Fallopian Tube
0.5 TPM
Bladder
0.5 TPM
OUTRAS DOENÇAS (2)
glucocorticoid-remediable aldosteronismcongenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency
HGNC:2591UniProt:P15538
HSD3B23 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

3-beta-HSD is a bifunctional enzyme, that catalyzes the oxidative conversion of Delta(5)-ene-3-beta-hydroxy steroid, and the oxidative conversion of ketosteroids. The 3-beta-HSD enzymatic system plays a crucial role in the biosynthesis of all classes of hormonal steroids

LOCALIZAÇÃO

Endoplasmic reticulum membraneMitochondrion membrane

VIAS BIOLÓGICAS (3)
Androgen biosynthesisMineralocorticoid biosynthesisGlucocorticoid biosynthesis
MECANISMO DE DOENÇA

Adrenal hyperplasia 2

A form of congenital adrenal hyperplasia, a common recessive disease due to defective synthesis of cortisol. Congenital adrenal hyperplasia is characterized by androgen excess leading to ambiguous genitalia in affected females, rapid somatic growth during childhood in both sexes with premature closure of the epiphyses and short adult stature. Four clinical types: 'salt wasting' (SW, the most severe type), 'simple virilizing' (SV, less severely affected patients), with normal aldosterone biosynthesis, 'non-classic form' or late-onset (NC or LOAH) and 'cryptic' (asymptomatic). In AH2, virilization is much less marked or does not occur. AH2 is frequently lethal in early life.

EXPRESSÃO TECIDUAL(Tecido-específico)
Glândula adrenal
1702.3 TPM
Intestino delgado
7.9 TPM
Testículo
1.0 TPM
Cólon transverso
0.9 TPM
Rim - Medula
0.6 TPM
OUTRAS DOENÇAS (1)
congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency
HGNC:5218UniProt:P26439
HSD11B111-beta-hydroxysteroid dehydrogenase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Controls the reversible conversion of biologically active glucocorticoids such as cortisone to cortisol, and 11-dehydrocorticosterone to corticosterone in the presence of NADP(H) (PubMed:10497248, PubMed:12460758, PubMed:14973125, PubMed:15152005, PubMed:15280030, PubMed:17593962, PubMed:21453287, PubMed:27927697, PubMed:30902677). Participates in the corticosteroid receptor-mediated anti-inflammatory response, as well as metabolic and homeostatic processes (PubMed:10497248, PubMed:12414862, Pub

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (2)
Glucocorticoid biosynthesisPrednisone ADME
MECANISMO DE DOENÇA

Cortisone reductase deficiency 2

An autosomal dominant error of cortisone metabolism characterized by a failure to regenerate cortisol from cortisone, resulting in increased cortisol clearance, activation of the hypothalamic- pituitary axis and ACTH-mediated adrenal androgen excess. Clinical features include hyperandrogenism resulting in hirsutism, oligo- amenorrhea, and infertility in females and premature pseudopuberty in males.

EXPRESSÃO TECIDUAL(Ubíquo)
Fígado
238.7 TPM
Ovário
78.2 TPM
Pulmão
55.7 TPM
Skin Not Sun Exposed Suprapubic
42.2 TPM
Fibroblastos
39.2 TPM
OUTRAS DOENÇAS (2)
cortisone reductase deficiency 2cortisone reductase deficiency
HGNC:5208UniProt:P28845
H6PDGDH/6PGL endoplasmic bifunctional proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Bifunctional enzyme localized in the lumen of the endoplasmic reticulum that catalyzes the first two steps of the oxidative branch of the pentose phosphate pathway/shunt, an alternative to glycolysis and a major source of reducing power and metabolic intermediates for biosynthetic processes (By similarity). Has a hexose-6-phosphate dehydrogenase activity, with broad substrate specificity compared to glucose-6-phosphate 1-dehydrogenase/G6PD, and catalyzes the first step of the pentose phosphate p

LOCALIZAÇÃO

Endoplasmic reticulum lumen

VIAS BIOLÓGICAS (1)
NADPH regeneration
MECANISMO DE DOENÇA

Cortisone reductase deficiency 1

An autosomal recessive error of cortisone metabolism characterized by a failure to regenerate cortisol from cortisone, resulting in increased cortisol clearance, activation of the hypothalamic-pituitary axis and ACTH-mediated adrenal androgen excess. Clinical features include hyperandrogenism resulting in hirsutism, oligo-amenorrhea, and infertility in females and premature pseudopuberty in males.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
105.0 TPM
Fígado
68.4 TPM
Fallopian Tube
67.9 TPM
Útero
66.8 TPM
Cervix Endocervix
60.6 TPM
OUTRAS DOENÇAS (2)
cortisone reductase deficiency 1cortisone reductase deficiency
HGNC:4795UniProt:O95479
CYP17A1Steroid 17-alpha-hydroxylase/17,20 lyaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

A cytochrome P450 monooxygenase involved in corticoid and androgen biosynthesis (PubMed:22266943, PubMed:25301938, PubMed:27339894, PubMed:9452426). Catalyzes 17-alpha hydroxylation of C21 steroids, which is common for both pathways. A second oxidative step, required only for androgen synthesis, involves an acyl-carbon cleavage. The 17-alpha hydroxy intermediates, as part of adrenal glucocorticoids biosynthesis pathway, are precursors of cortisol (Probable) (PubMed:25301938, PubMed:9452426). Hyd

LOCALIZAÇÃO

Endoplasmic reticulum membraneMicrosome membrane

VIAS BIOLÓGICAS (2)
Androgen biosynthesisGlucocorticoid biosynthesis
MECANISMO DE DOENÇA

Adrenal hyperplasia 5

A form of congenital adrenal hyperplasia, a common recessive disease due to defective synthesis of cortisol. Congenital adrenal hyperplasia is characterized by androgen excess leading to ambiguous genitalia in affected females, rapid somatic growth during childhood in both sexes with premature closure of the epiphyses and short adult stature. Four clinical types: 'salt wasting' (SW, the most severe type), 'simple virilizing' (SV, less severely affected patients), with normal aldosterone biosynthesis, 'non-classic form' or late-onset (NC or LOAH) and 'cryptic' (asymptomatic).

EXPRESSÃO TECIDUAL(Tecido-específico)
Glândula adrenal
6921.5 TPM
Testículo
14.6 TPM
Tireoide
6.3 TPM
Rim - Medula
4.7 TPM
Rim - Córtex
4.7 TPM
OUTRAS DOENÇAS (2)
congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency17,20-lyase deficiency, isolated
HGNC:2593UniProt:P05093
PORNADPH--cytochrome P450 reductaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

This enzyme is required for electron transfer from NADP to cytochrome P450 in microsomes. It can also provide electron transfer to heme oxygenase and cytochrome B5

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Cytochrome P450 - arranged by substrate type
MECANISMO DE DOENÇA

Antley-Bixler syndrome, with genital anomalies and disordered steroidogenesis

A disease characterized by the association of Antley-Bixler syndrome with steroidogenesis defects and abnormal genitalia. Antley-Bixler syndrome is characterized by craniosynostosis, radiohumeral synostosis present from the perinatal period, midface hypoplasia, choanal stenosis or atresia, femoral bowing and multiple joint contractures.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
164.2 TPM
Fígado
149.3 TPM
Tireoide
116.3 TPM
Pituitária
84.0 TPM
Pulmão
67.2 TPM
OUTRAS DOENÇAS (2)
congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiencyAntley-Bixler syndrome with genital anomalies and disordered steroidogenesis
HGNC:9208UniProt:P16435
NR3C1Glucocorticoid receptorDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Receptor for glucocorticoids (GC) (PubMed:27120390, PubMed:37478846). Has a dual mode of action: as a transcription factor that binds to glucocorticoid response elements (GRE), both for nuclear and mitochondrial DNA, and as a modulator of other transcription factors (PubMed:28139699). Affects inflammatory responses, cellular proliferation and differentiation in target tissues. Involved in chromatin remodeling (PubMed:9590696). Plays a role in rapid mRNA degradation by binding to the 5' UTR of ta

LOCALIZAÇÃO

CytoplasmNucleusMitochondrionCytoplasm, cytoskeleton, spindleCytoplasm, cytoskeleton, microtubule organizing center, centrosomeChromosomeNucleus, nucleoplasm

VIAS BIOLÓGICAS (6)
PTK6 ExpressionRegulation of RUNX2 expression and activityRegulation of NPAS4 gene transcriptionFOXO-mediated transcription of oxidative stress, metabolic and neuronal genesSUMOylation of intracellular receptors
MECANISMO DE DOENÇA

Glucocorticoid resistance, generalized

An autosomal dominant disease characterized by increased plasma cortisol concentration and high urinary free cortisol, resistance to adrenal suppression by dexamethasone, and the absence of Cushing syndrome typical signs. Clinical features include hypoglycemia, hypertension, metabolic alkalosis, chronic fatigue and profound anxiety.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
55.3 TPM
Nervo tibial
34.5 TPM
Tecido adiposo
34.1 TPM
Fibroblastos
33.6 TPM
Artéria tibial
32.7 TPM
OUTRAS DOENÇAS (2)
glucocorticoid resistanceCushing disease due to pituitary adenoma
HGNC:7978UniProt:P04150

Medicamentos e terapias

PREDNISOLONEPhase 4

Mecanismo: Glucocorticoid receptor agonist

CORTISONE ACETATEPhase 4

Mecanismo: Glucocorticoid receptor agonist

DEXAMETHASONE SODIUM PHOSPHATEPhase 4

Mecanismo: Glucocorticoid receptor agonist

DEXAMETHASONEPhase 4

Mecanismo: Glucocorticoid receptor agonist

HYDROCORTISONEPhase 4

Mecanismo: Glucocorticoid receptor agonist

PREDNISONEPhase 4

Mecanismo: Glucocorticoid receptor agonist

FLUDROCORTISONE ACETATEPhase 4

Mecanismo: Mineralocorticoid receptor agonist

CRINECERFONTPhase 3

Mecanismo: Corticotropin releasing factor receptor 1 antagonist

NEVANIMIBEPhase 2

Mecanismo: Acyl coenzyme A:cholesterol acyltransferase 1 inhibitor

ABIRATERONE ACETATEPhase 2

Mecanismo: Cytochrome P450 17A1 inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

686 variantes patogênicas registradas no ClinVar.

🧬 CYP21A2: NM_000500.9(CYP21A2):c.1381_1398del (p.Ser461_Pro466del) ()
🧬 CYP21A2: NM_000500.9(CYP21A2):c.710_719delinsAGGAGGAGAA (p.Ile237_Met240delinsLysGluGluLys) ()
🧬 CYP21A2: NM_000500.9(CYP21A2):c.1088C>T (p.Ala363Val) ()
🧬 CYP21A2: NM_000500.9(CYP21A2):c.738+2T>C ()
🧬 CYP21A2: NM_000500.9(CYP21A2):c.1301T>C (p.Leu434Pro) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado7
3Fase 31
2Fase 22
Medicamentos catalogadosEnsaios clínicos· 10 medicamentos · 0 ensaios
✓ Aprovados — podem ser usados hoje
PREDNISOLONECORTISONE ACETATEDEXAMETHASONE SODIUM PHOSPHATEDEXAMETHASONEHYDROCORTISONEPREDNISONEFLUDROCORTISONE ACETATE
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome adrenogenital

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
26 papers (10 anos)
#1

Long-term outcomes in patients with congenital adrenal hyperplasia treated with hydrocortisone modified-release hard capsules.

European journal of endocrinology2025 Jun 30

Hydrocortisone modified-release hard capsules (MRHC, development name Chronocort) replace the physiological overnight cortisol rise and improve the biochemical control of congenital adrenal hyperplasia (CAH). This study aims to evaluate long-term safety, tolerability, and efficacy of MRHC. This is an open-label follow-on study. Ninety-one patients with classic CAH, mean age 37 years, 68% female, 32% male, entered the study and 22 discontinued. Median treatment duration was 4 years (range 0.2-5.8). Median hydrocortisone dose at study entry was 30 mg/day and reduced to 20 mg/day after 24 weeks and stayed stable thereafter until 48 months (P < .0001). Disease control improved on MRHC for the steroid disease markers serum 17-hydroxyprogesterone (17OHP) (P < .03) and androstenedione (A4) (P < .002). After 4 years, the majority of patients had a 17OHP < 4-fold upper limit of normal (ULN) (71%) and an A4 <ULN (90%). Measurement of 17OHP and A4 at 09:00 h and 13:00 h gave similar results. Of the 37 women < 50 years of age who were not on contraceptives over the whole study period, 5 became pregnant (13.5%). Of the men, 13.8% (4/29) had a partner pregnancy. Seven patients had an adrenal crisis with 1 patient reporting 8 of these giving an incidence of 3.9 crises per 100 patient years. Modified-release hard capsule treatment resulted in hydrocortisone dose reduction followed by a stable dose with improved biochemical control associated with fertility. Biochemical control could be reliably monitored by a single blood sample taken between 09:00 and 13:00 h. The incidence of adrenal crises was below that reported previously in patients with CAH.

#2

46, XX DSD with Atypical Genitalia: Clinical Insights and Diagnostic Approaches.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme2025 Apr

Congenital adrenal hyperplasia (CAH) is a rare disorder with autosomal recessive inheritance; it was historically known as adrenogenital syndrome. Patients with virilizing forms of CAH and a 46,XX karyotype present with varied degrees of hyperandrogenism due to different genetic defects in the adrenal steroidogenesis pathway. This comprehensive review describes a simplified diagnostic approach for patients with atypical genitalia and 46, XX DSD. It highlights the importance of a detailed history and clinical examination, with specific pointers toward the etiological diagnosis. There is a need for utilizing standardized liquid chromatography/tandem mass spectrometry (LC-MS/MS) assays to accurately diagnose these disorders of steroidogenesis. Choosing appropriate molecular testing methods has significant implications for establishing the diagnosis and providing genetic counseling.

#3

Bilateral testicular mass in a 21-year-old male with a history of congenital adrenal hyperplasia: A case report.

Urology case reports2025 Mar

A 21-year-old man was referred because of bilateral testicular swelling from 8 months ago. He had a known history of congenital adrenal hyperplasia (21-hydroxylase deficiency) diagnosed in infancy, managed with glucocorticoid therapy since childhood. However, the patient had been non-adherent to medication for several years. The patient underwent surgery with an inguinal incision, and a biopsy from the mass was sent for frozen section. The frozen and permanent sections were consistent with "Testicular adrenal rest tumor (tumor of adrenogenital syndrome).

#4

[Not Available].

Ugeskrift for laeger2024 Mar 11

Congenital adrenal hyperplasia (CAH) arises from genetic enzyme defects, often in CYP21A2, causing primary adrenal insufficiency. In this case report, a man in his late 20s with lifelong CAH faced challenges in adhering to medication. Suboptimal treatment led to the development of testicular adrenal rest tumours, diagnosed by ultrasound, and hypogonadism. Enhanced adherence restored hormone levels, promoting eugonadism. Adherence plays a crucial role in diminishing tumour size and preventing complications, potentially necessitating orchiectomy in severe cases.

#5

[Testicular adrenal rest tumors (TARTs) and adrenogenital syndrome (AGS) - Do not mix up with malignant testicular tumors!].

MMW Fortschritte der Medizin2024 Feb

Testicular adrenal rest tumors and adrenogenital syndrome (AGS) - Do not mix up with malignant testicular tumors! Testicular adrenal residual tumors (TARTs) frequently occur in men with adrenogenital syndrome. Without knowledge of AGS, diagnosis is problematic due to difficult differentiation from other testicular tumors. However, early treatment is crucial for maintaining or regaining fertility, among other aspects. This article provides background knowledge for general practitioners.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC679 artigos no totalmostrando 28

2025

Long-term outcomes in patients with congenital adrenal hyperplasia treated with hydrocortisone modified-release hard capsules.

European journal of endocrinology
2025

46, XX DSD with Atypical Genitalia: Clinical Insights and Diagnostic Approaches.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
2025

Bilateral testicular mass in a 21-year-old male with a history of congenital adrenal hyperplasia: A case report.

Urology case reports
2024

[Testicular adrenal rest tumors (TARTs) and adrenogenital syndrome (AGS) - Do not mix up with malignant testicular tumors!].

MMW Fortschritte der Medizin
2024

[The androgenital syndrome: Don't just think about it in childhood!].

MMW Fortschritte der Medizin
2022

Congenital adrenal hyperplasia. Role of dentist in early diagnosis.

Open medicine (Warsaw, Poland)
2022

Taking "Trans-ano-rectal" out of ASTRA: An anterior sagittal approach without splitting the rectum.

Journal of pediatric urology
2021

Atypical Presentation of Testicular Adrenal Rest Tumor (TART) Leading to Bilateral Partial Orchiectomy in a 31-Year-Old Adult Revealing Primary Adrenal Insufficiency with CYP11A1 Deficiency.

Case reports in endocrinology
2022

Transitional cell metaplasia of the uterine cervix: A histopathological and immunohistochemical analysis suggesting a possible role of androgenic conversion during urothelial-like differentiation in peri/postmenopausal women.

Annals of diagnostic pathology
2021

Novel SCNN1A gene splicing-site mutation causing autosomal recessive pseudohypoaldosteronism type 1 (PHA1) in two Italian patients belonging to the same small town.

Italian journal of pediatrics
2021

Incidental Finding of Bilateral Ovarian Adrenal Rest Tumor in a Patient With Congenital Adrenal Hyperplasia: A Case Report and Brief Review.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
2020

Disorders of Sex Development: Classification, Review, and Impact on Fertility.

Journal of clinical medicine
2020

COMPLEX ORPHAN PATHOLOGY: COMORBIDITY OF MUCOVISCIDOSIS AND CONGENITAL DYSFUNCTION OF ADRENAL GLANDS CORTEX (REFERENCES REVIEW AND OWN RESEARCH).

Wiadomosci lekarskie (Warsaw, Poland : 1960)
2020

[Hyperandrogenism, adrenal dysfunction, and hirsutism].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
2020

Congenital adrenal hyperplasia: Does repair after two years of age have a worse outcome?

Journal of pediatric urology
2019

Exome-based search for recurrent disease-causing alleles in Russian population.

European journal of medical genetics
2018

Genitoplasty in newborn females with adrenogenital syndrome: Focus on the reconstruction technique and its outcomes.

Journal of pediatric urology
2018

A rare case of hydrometrocolpos from persistent urogenital sinus in patient affected by adrenogenital syndrome.

Journal of ultrasound
2018

Giant Cavernous Hemangioma of the Adrenal Gland in an Elderly Patient.

Internal medicine (Tokyo, Japan)
2017

Testicular tumors of adrenogenital syndrome: From physiopathology to therapy.

Presse medicale (Paris, France : 1983)
2017

Reduced steroidogenesis in patients with PCDH19-female limited epilepsy.

Epilepsia
2016

Immunophenotypic differences between neoplastic and non-neoplastic androgen-producing cells containing and lacking Reinke crystals.

Virchows Archiv : an international journal of pathology
2016

Should CAH in Females Be Classified as DSD?

Frontiers in pediatrics
2016

Idiopathic female pseudohermaphroditism with urethral duplication and female hypospadias.

BMJ case reports
2016

Leydig cell tumour and giant adrenal myelolipoma associated with adrenogenital syndrome: a case report with a review of the literature.

Urologia
2015

Bilateral Idiopathic Adrenal Hyperplasia: Genetics and Beyond.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
2015

Metachronous Bilateral Testicular Leydig-Like Tumors Leading to the Diagnosis of Congenital Adrenal Hyperplasia (Adrenogenital Syndrome).

Case reports in pathology
2014

Gender Dysphoria in 46,XX Persons with Adrenogenital Syndrome Raised as Females: An Addendum.

Frontiers in pediatrics
Ver todos os 679 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome adrenogenital.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome adrenogenital

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Long-term outcomes in patients with congenital adrenal hyperplasia treated with hydrocortisone modified-release hard capsules.
    European journal of endocrinology· 2025· PMID 40576296mais citado
  2. 46, XX DSD with Atypical Genitalia: Clinical Insights and Diagnostic Approaches.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme· 2025· PMID 40043726mais citado
  3. Bilateral testicular mass in a 21-year-old male with a history of congenital adrenal hyperplasia: A case report.
    Urology case reports· 2025· PMID 39974304mais citado
  4. [Not Available].
    Ugeskrift for laeger· 2024· PMID 38533865mais citado
  5. [Testicular adrenal rest tumors (TARTs) and adrenogenital syndrome (AGS) - Do not mix up with malignant testicular tumors!].
    MMW Fortschritte der Medizin· 2024· PMID 38376683mais citado
  6. [The androgenital syndrome: Don't just think about it in childhood!].
    MMW Fortschr Med· 2024· PMID 38376682recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:181412(Orphanet)
  2. MONDO:0015898(MONDO)
  3. GARD:20226(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q13368382(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome adrenogenital
Compêndio · Raras BR

Síndrome adrenogenital

ORPHA:181412 · MONDO:0015898
CID-10
E25 · Transtornos adrenogenitais
CID-11
Medicamentos
10 registrados
MedGen
UMLS
C0302280
Repurposing
1 candidato
fludrocortisone-acetate
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades